Drug Interaction in Infectious Diseases


The medical harm which can be majorly prevented is drug interactions in the infectious diseases. Drug interactions represent a major risk to patients. The approved drug product labels for anti-infective drugs, direct-acting antivirals for HCV, HIV drugs unveil that drug interactions present a huge challenge for patients and their healthcare providers. Non-CYP enzymes, CYP enzymes, and changes in gastric pH, the ever-growing list of drug transporters may be the cause of interactions. There are other considerations which incorporate interactions due to food components, herbal medications and biological products.


  • Bacteria
  • Fungi
  • Protoazoa
  • Parasitology

Related Conference of Drug Interaction in Infectious Diseases

May 10-11, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore
May 27-28, 2021

7th Rare Diseases and Orphan Drugs

Vienna, Austria
July 19-20, 2021

13th Global Infections Conference

Tokyo, Japan
September 06-07, 2021

11th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany
October 21-22, 2021

International Conference on Tropical Diseases and Cure

Zurich, Switzerland
November 22-23, 2021

3rd World Congress on Advancements in Tuberculosis and Lung Diseases

Singapore City, Singapore
February 07-08, 2022

9th International Congress on Infectious Diseases

Aberdeen, UK

Drug Interaction in Infectious Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in